AI-Driven Advancements in Pharmacy: Enhancing Drug Discovery, Optimization and Clinical Decision-Making


Authors : Ashish L. Pohane; Dr. Sachin J. Dighade; Esha S. Rithe; Reema R. Mangwani; Akshay S. Raut; Samiksha S. Bhamburkar

Volume/Issue : Volume 10 - 2025, Issue 3 - March

Google Scholar : https://tinyurl.com/3s9swdy3

Scribd : https://tinyurl.com/yeyacbmt

DOI : https://doi.org/10.38124/ijisrt/25mar533

PlumX Metrics

Semantic Scholar

ResearchGate

IJISRT Repository

Google Scholar

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 15 to 20 days to display the article.

Abstract : Artificial Intelligence (AI) has emerged as a transformative force in pharmacy, reshaping drug discovery, medication management, and patient care. The integration of AI-driven methodologies, including machine learning, natural language processing (NLP), computer vision, and predictive analytics, has revolutionized pharmaceutical operations, enhancing efficiency, accuracy, and patient safety. AI-driven systems facilitate personalized medicine, clinical decision support, automated dispensing, and pharmacovigilance, thereby minimizing medication errors and optimizing treatment regimens. This paper explores the historical evolution, applications, benefits, and challenges associated with AI in pharmacy. The adoption of AI-driven predictive analytics aids in adverse drug reaction detection, patient risk stratification, and treatment optimization, while automated decision support systems enhance clinical accuracy and regulatory compliance. Deep learning and supervised learning models are extensively employed in drug discovery and development, significantly accelerating the identification of therapeutic candidates and repurposing existing medications. Moreover, AI-based inventory management and supply chain forecasting improve pharmaceutical logistics, reducing medication waste and ensuring optimal drug availability. Despite its vast potential, AI implementation in pharmacy is accompanied by ethical, regulatory, and financial challenges, including data privacy concerns, algorithmic bias, workforce displacement, and the need for continuous learning systems. The complexity of AI decision-making, particularly the "black box" problem, raises concerns regarding transparency and interpretability in clinical practice. Regulatory frameworks, such as GDPR and FDA guidelines, continue to evolve to address AI’s ethical and safety implications in pharmaceutical applications. As AI technology advances, its role in pharmacy will expand further, leading to improved medication safety, cost reduction, and enhanced patient engagement. By integrating supervised and unsupervised AI models, alongside IoT-driven monitoring systems, the pharmaceutical industry is poised to transition towards a more data-driven, predictive, and patient- centered approach to healthcare. This paper provides a comprehensive examination of AI’s current and potential applications in pharmacy, emphasizing the necessity for interdisciplinary collaboration, ethical AI governance, and ongoing research to fully harness its capabilities.

References :

  1. SHUKLA, T., 2024. Beyond Diagnosis: AI’s Role in Preventive Healthcare and Early Detection.
  2. Chomutare, T., Tejedor, M., Svenning, T.O., Marco-Ruiz, L., Tayefi, M., Lind, K., Godtliebsen, F., Moen, A., Ismail, L., Makhlysheva, A. and Ngo, P.D., 2022. Artificial intelligence implementation in healthcare: a theory-based scoping review of barriers and facilitators. International Journal of Environmental Research and Public Health, 19(23), p.16359.
  3. Litjens, G., Ciompi, F., Wolterink, J.M., de Vos, B.D., Leiner, T., Teuwen, J. and Išgum, I., 2019. State-of-the-art deep learning in cardiovascular image analysis. JACC: Cardiovascular imaging, 12(8 Part 1), pp.1549-1565.
  4. Bates, D.W., Saria, S., Ohno-Machado, L., Shah, A. and Escobar, G., 2014. Big data in health care: using analytics to identify and manage high-risk and high-cost patients. Health affairs, 33(7), pp.1123-1131.
  5. Weissler, E.H., Naumann, T., Andersson, T., Ranganath, R., Elemento, O., Luo, Y., Freitag, D.F., Benoit, J., Hughes, M.C., Khan, F. and Slater, P., 2021. The role of machine learning in clinical research: transforming the future of evidence generation. Trials, 22, pp.1-15.
  6. Dasta, J.F., 1992. Application of artificial intelligence to pharmacy and medicine. Hospital pharmacy, 27(4), pp.312-5.
  7. Raza, M.A., Aziz, S., Noreen, M., Saeed, A., Anjum, I., Ahmed, M. and Raza, S.M., 2022.  Artificial  intelligence  (AI)  in  pharmacy:  an  overview  of innovations. INNOVATIONS in pharmacy, 13(2).
  8. Hamet, P. and Tremblay, J., 2017. Artificial intelligence in medicine. metabolism, 69, pp.S36-S40..
  9. Baclic, O., Tunis, M., Young, K., Doan, C., Swerdfeger, H. and Schonfeld, J., 2020. Artificial intelligence in public health: Challenges and opportunities for public health made possible by advances in natural language processing. Canada Communicable Disease Report, 46(6), p.161.
  10. Mishra, V., 2018. Artificial intelligence: the beginning of a new era in pharmacy profession. Asian Journal of Pharmaceutics (AJP), 12(02).
  11. Dentzer, S., 2019. Creating the future of artificial intelligence in health-system pharmacy. American Journal of Health-System Pharmacy, 76(24), pp.1995-1996.
  12. Gudadappanavar, A., Hombal, P. and Benni, J., 2024. An Evidence-Based Systematic Review: The Impact of Artificial Intelligence in Pharmacology and Health Research. Physiology and Pharmacology, 28(3), pp.257-270.
  13. Dentzer, S., 2019. Creating the future of artificial intelligence in health-system pharmacy. American Journal of Health-System Pharmacy, 76(24), pp.1995-1996.
  14. Schutz, N., Olsen, C.A., McLaughlin, A.J., Yi, W.M., Nelson, S.D., Kalichira, A.L., Smith, A.H., Miller, K.A., Le, T., Chaffee, B.W. and Worthy Woodbury, C.K., 2020. ASHP statement on the use of artificial intelligence in pharmacy. American Journal of Health-System Pharmacy, 77(23), pp.2015-2018.
  15. Alanazi, R.J., 2024. Role of Artificial Intelligence in Pharmacy Practice: A Systematic Review. Archives of Pharmacy Practice, 15(2-2024), pp.34-42
  16. Choudhury, A. and Asan, O., 2020. Role of artificial intelligence in patient safety outcomes: systematic literature review. JMIR medical informatics, 8(7), p.e18599.
  17. Tarumi, S., Takeuchi, W., Chalkidis, G., Rodriguez-Loya, S., Kuwata, J., Flynn, M., Turner, K.M., Sakaguchi, F.H., Weir, C., Kramer, H. and Shields, D.E., 2021. Leveraging artificial intelligence to improve chronic disease care: methods and application to pharmacotherapy decision support for type-2 diabetes mellitus. Methods of Information in Medicine, 60(S 01), pp.e32-e43.
  18. Vo, T.H., Nguyen, N.T.K., Kha, Q.H. and Le, N.Q.K., 2022. On the road to explainable AI in drug-drug interactions prediction: A systematic review. Computational and Structural Biotechnology Journal, 20, pp.2112-2123.
  19. Bu, F., Sun, H., Li, L., Tang, F., Zhang, X., Yan, J., Ye, Z. and Huang, T., 2022. Artificial intelligence-based internet hospital pharmacy services in China: perspective based on a case study. Frontiers in Pharmacology, 13, p.1027808.
  20. Ranchon, F., Chanoine, S., Lambert-Lacroix, S., Bosson, J.L., Moreau-Gaudry, A. and Bedouch, P., 2023. Development of artificial intelligence powered apps and tools for clinical pharmacy services: A systematic review. International Journal of Medical Informatics, 172, p.104983
  21. Ye, J., 2023. Patient safety of perioperative medication through the lens of digital health and artificial intelligence. JMIR Perioperative Medicine, 6, p.e34453.
  22. Tarumi, S., Takeuchi, W., Chalkidis, G., Rodriguez-Loya, S., Kuwata, J., Flynn, M., Turner, K.M., Sakaguchi, F.H., Weir, C., Kramer, H. and Shields, D.E., 2021. Leveraging artificial intelligence to improve chronic disease care: methods and application to pharmacotherapy decision support for type-2 diabetes mellitus. Methods of Information in Medicine, 60(S 01), pp.e32-e43.
  23. Dutta, S., Mukherjee, U. and Bandyopadhyay, S.K., 2021. Pharmacy impact on Covid- 19 vaccination progress using machine learning approach. J. Pharm. Res. Int, 33, pp.202-217.
  24. Del Rio-Bermudez, C., Medrano, I.H., Yebes, L. and Poveda, J.L., 2020. Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy. Journal of Pharmaceutical Policy and Practice, 13(1), p.75.
  25. Floryanzia, S., Ramesh, P., Mills, M., Kulkarni, S., Chen, G., Shah, P. and Lavrich, D., 2022. Disintegration testing augmented by computer Vision technology. International Journal of Pharmaceutics, 619, p.121668.
  26. Imai, S., 2024. Data-Driven Clinical Pharmacy Research: Utilizing Machine Learning and Medical Big Data. Biological and Pharmaceutical Bulletin, 47(10), pp.1594-1599.
  27. Wetsiri, W. and Paireekreng, W., 2024, June. Enhancing Operational Efficiency in Community Pharmacies through Robotic Process Automation. In 2024 5th Technology Innovation Management and Engineering Science International Conference (TIMES- iCON) (pp. 1-6). IEEE.
  28. Trenfield, S.J., Awad, A., McCoubrey, L.E., Elbadawi, M., Goyanes, A., Gaisford, S. and Basit, A.W., 2022. Advancing pharmacy and healthcare with virtual digital technologies. Advanced Drug Delivery Reviews, 182, p.114098.
  29. Pothecary, A., Griffiths, S., Bastian, L. and Hill, A., 2023. A Service Evaluation of the Implementation of E-sign for Homecare Prescriptions in Secondary Care. International Journal of Pharmacy Practice, 31(Supplement_2), pp.ii45-ii45.
  30. Rosenberg, J., Fiebelkorn, K., Maerten-Rivera, J., Stumm, C., Matecki, C., Zhao, Y., Robinson, S. and Pizzutelli, N., 2023. Evaluation of a Pharmacy Summer Camp to Recruit Students to the Field of Pharmacy. American Journal of Pharmaceutical Education, 87(11), p.100567.
  31. Vora, L.K., Gholap, A.D., Jetha, K., Thakur, R.R.S., Solanki, H.K. and Chavda, V.P., 2023. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics, 15(7), p.1916.

Artificial Intelligence (AI) has emerged as a transformative force in pharmacy, reshaping drug discovery, medication management, and patient care. The integration of AI-driven methodologies, including machine learning, natural language processing (NLP), computer vision, and predictive analytics, has revolutionized pharmaceutical operations, enhancing efficiency, accuracy, and patient safety. AI-driven systems facilitate personalized medicine, clinical decision support, automated dispensing, and pharmacovigilance, thereby minimizing medication errors and optimizing treatment regimens. This paper explores the historical evolution, applications, benefits, and challenges associated with AI in pharmacy. The adoption of AI-driven predictive analytics aids in adverse drug reaction detection, patient risk stratification, and treatment optimization, while automated decision support systems enhance clinical accuracy and regulatory compliance. Deep learning and supervised learning models are extensively employed in drug discovery and development, significantly accelerating the identification of therapeutic candidates and repurposing existing medications. Moreover, AI-based inventory management and supply chain forecasting improve pharmaceutical logistics, reducing medication waste and ensuring optimal drug availability. Despite its vast potential, AI implementation in pharmacy is accompanied by ethical, regulatory, and financial challenges, including data privacy concerns, algorithmic bias, workforce displacement, and the need for continuous learning systems. The complexity of AI decision-making, particularly the "black box" problem, raises concerns regarding transparency and interpretability in clinical practice. Regulatory frameworks, such as GDPR and FDA guidelines, continue to evolve to address AI’s ethical and safety implications in pharmaceutical applications. As AI technology advances, its role in pharmacy will expand further, leading to improved medication safety, cost reduction, and enhanced patient engagement. By integrating supervised and unsupervised AI models, alongside IoT-driven monitoring systems, the pharmaceutical industry is poised to transition towards a more data-driven, predictive, and patient- centered approach to healthcare. This paper provides a comprehensive examination of AI’s current and potential applications in pharmacy, emphasizing the necessity for interdisciplinary collaboration, ethical AI governance, and ongoing research to fully harness its capabilities.

Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe